A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplant...
Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer ...
Recommended dose selected for evaluation of anti-tumor activity in the ongoing Phase 2a portion of the Phase 1/2a study 23andMe Holding Co. (Nasdaq: M...
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sy...
The published data showcase how Evaxion's proprietary AI-platform, RAVEN (Rapidly Adaptive Viral Response), identifies broad and robust T-cell epitopes fro...
Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and serv...
Cognizant (NASDAQ: CTSH) announced it is working with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to advance the speed and q...
- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today unveiled three global Centers of Excellence (COEs) to gain greater ...
The research was in collaboration with the Samsung Medical Center, Sungkyunkwan University School of Medicine. This study adds to the previous studies of p...
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists...
Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced a s...
The U.S. Department of Health and Human Services plans to end the federal COVID-19 Public Health Emergency on May 11, but ensuring access to novel vac...
RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of inn...
© 2025 Biopharma Boardroom. All Rights Reserved.
